Otsuka Pharmaceutical Companies (U.S.)
Pharmaceutical development and commercialization
- B2B
- Has physical offices
- Manufacturing
- Multi-product
- Sales-led purchase
About Otsuka Pharmaceutical Companies (U.S.)
Commercialization of discovered and licensed pharmaceutical products in North America and global clinical development and registration of healthcare products.
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001–5,000 employees
- Headquarters
- Princeton, New Jersey, United States
- Revenue
- $291M – $2.3BTamtam estimate
- Website
- otsuka-us.com
Otsuka Pharmaceutical Companies (U.S.) in the news
- (sibeprenlimab-szsi) Preserved Kidney Function Over 12 Months in IgA Nephropathy (IgAN)
Otsuka Pharmaceutical's VOYXACT preserved kidney function and slowed disease progression in adults with primary IgA nephropathy during a 12-month Phase 3 trial.
- Otsuka Presents New Phase 3 Post Hoc Analyses of Centanafadine Highlighting Improvement in Executive Function and Emotional Dysregulation in Adults with ADHD at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting
New Phase 3 clinical data shows centanafadine improves executive function and emotional dysregulation in adults with ADHD, with an FDA target action date set for July 2026.
- Otsuka Pharmaceutical to acquire Transcend Therapeutics in $700M deal
Otsuka Pharmaceutical is purchasing Transcend Therapeutics for $700 million to expand its drug development capabilities.
- Otsuka Pharmaceutical to Acquire Transcend Therapeutics
Otsuka Pharmaceutical is acquiring Transcend Therapeutics for up to $1.225 billion to obtain a breakthrough PTSD treatment and expand its psychiatric drug pipeline.
- Leading in the Psychedelic Space: Q&A with Tarek Rabah
Strategic expansion into psychedelics and autoimmune therapies aims to address high unmet medical needs in mental health and nephrology.
Otsuka Pharmaceutical Companies (U.S.) at a glance
Otsuka Pharmaceutical Companies (U.S.) is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Princeton, New Jersey, United States.
Otsuka Pharmaceutical Companies (U.S.) has 1,001–5,000 employees.
Otsuka Pharmaceutical Companies (U.S.)'s revenue is $291M – $2.3B (Tamtam estimate).
Selling to companies like Otsuka Pharmaceutical Companies (U.S.)?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies